At Neuliven Health, we’re fans of healthy aging. Aging is a natural part of life. We want our customers to live long, healthy, happy lives. Many anti-aging products market themselves by claiming that aging is bad and something to be avoided. Unhealthy aging is undoubtedly something to steer away from. But the idea that aging in and of itself is a negative is silly. Getting older is just a part of living. The important thing is to stay healthy and active.
The research comes from David Sinclair. He is a “longevity guru” to claimed in 2006 that rodents who took resveratrol had slower aging. He made more than $720 million off the claim and resveratrol drugs. But his research was debunked and proven to be false.
While this new research is backed by Harvard, many scientists are taking it with more than a grain of salt as it was led by Dr. Sinclair. Some have pointed out that it hasn’t been proven to be effective in animals. Dr. Sinclair’s team disagrees and claims it has worked in both mice and monkeys. Others have pointed out that the cocktail has compounds that are “generally not safe alone or in a combination.”
The drug combination includes but is not limited to growth hormone, metformin and one that activates the enzyme AMPK. Dr. Sinclair says it is an affordable way to cause “whole-body rejuvenation.”
The new paper was published in the respected journal Aging. It is built off of Nobel Prize-winning research. But, unsurprisingly, there is skepticism around it as Dr. Sinclair has made a fortune and a reputation off of false claims.
“Until recently, the best we could do was slow aging,” said Dr. Sinclair. “New discoveries suggest we can now reverse it. This process has previously required gene therapy, limiting its widespread use.”
The team of researchers has scientists from MIT and Harvard. They are preparing for a human trail. We hope that the tests are successful and that this treatment can reverse or at least treat age-related illnesses.
Interestingly, while many new sites are speaking about this new discovery, neither Harvard nor MIT have published any press releases about it yet. That might just be a coincidence. The press might have gotten information about it before their press offices could write a release. But it is unusual for universities not to push the research they are proud of out to the public through their press office.
We’ll have to wait and see what the human trials say. This could be a huge breakthrough that is a wonderful tool to aid healthy aging. Until we hear more about it, it’s best to remain cautiously optimistic.
